To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us." -Dr. John Farley

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.

"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.

This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Give Him 15: Mercy is Our New Currency

A Little Baby Girl Is Rescued from a Dumpster in Texas. A Dumpster

Nonprofit Asks Feds to Investigate Schools' 'Gender-Affirming Care' Practices

Latest Move by the President to Prevent a Government Shutdown Is Brilliant

Trump Closes Loophole Allowing Illegal Aliens to Drive Commercial Trucks After Tragic Accidents

Trump's Administration Finds 25,000 Missing Migrant Children

Autism, What We Know: Science Backs Up President Trump's Statements

Former FBI Director James Comey Indicted by Grand Jury for Obstruction in Russia Hoax Investigation

The Spiritual Battle is REAL!: Sean McDowell's Son Encounters a 'Demon' While Evangelizing in NYC

3 Suspects Arrested after Houston Youth Baseball Coach Shot during Pregame Prayer With Kids

Explosive Clash: Dearborn Mayor Attacks Resident Who Objected to Terrorist Street Naming

Economy: Second Quarter GDP Revised Up – Again – to Best Quarter Since 2023

DOGE Helped Uncover the Biggest Health Care Heist in American History

Charlie's TPUSA Campus Tours Continue as Virginia Tech Venue Fills to Max Capacity

Justice Department Seeks to Indict Former FBI Director James Comey before Looming Deadline, for Allegedly Lying to Congress

What Happens When You 'Pause' Your Child's Puberty? The Answer Is Even More Devastating Than You'd Think

Texas Bans Gender-Confused People from Using Opposite-Sex Facilities in Public Schools, Prisons

NBC Forced to Retract Claim that ICE Used 5-Year-Old Autistic Girl as 'Bait'; In Reality, Her Criminal Alien Father Abandoned Her in a Car and Agents Rescued the Child

President Trump Urges UN to Protect 'The Most Persecuted Religion on the Planet Today: Christianity'

Secret Service Finds, Dismantles Massive 'Telecommunications Threat' Near UN General Assembly in New York

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor